000 01722 a2200505 4500
005 20250514034311.0
264 0 _c20020716
008 200207s 0 0 eng d
022 _a1527-2729
024 7 _a10.1007/s11864-001-0024-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDeAngelis, L M
245 0 0 _aPrimary central nervous system lymphomas.
_h[electronic resource]
260 _bCurrent treatment options in oncology
_cAug 2001
300 _a309-18 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdrenal Cortex Hormones
_xtherapeutic use
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnticonvulsants
_xtherapeutic use
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aBiopsy
_xmethods
650 0 4 _aBrain Neoplasms
_xdiagnosis
650 0 4 _aCombined Modality Therapy
650 0 4 _aContraindications
650 0 4 _aCranial Irradiation
_xadverse effects
650 0 4 _aCraniotomy
650 0 4 _aDiagnostic Imaging
650 0 4 _aEye
_xpathology
650 0 4 _aHumans
650 0 4 _aInjections, Spinal
650 0 4 _aLymphoma, AIDS-Related
_xdiagnosis
650 0 4 _aLymphoma, Non-Hodgkin
_xdiagnosis
650 0 4 _aMeninges
_xpathology
650 0 4 _aMethotrexate
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Invasiveness
650 0 4 _aSeizures
_xetiology
650 0 4 _aStereotaxic Techniques
650 0 4 _aSurvival Analysis
650 0 4 _aTreatment Outcome
650 0 4 _aVitrectomy
773 0 _tCurrent treatment options in oncology
_gvol. 2
_gno. 4
_gp. 309-18
856 4 0 _uhttps://doi.org/10.1007/s11864-001-0024-6
_zAvailable from publisher's website
999 _c11953142
_d11953142